[go: up one dir, main page]

WO2017216696A1 - Determining blood type by tube facilitated - Google Patents

Determining blood type by tube facilitated Download PDF

Info

Publication number
WO2017216696A1
WO2017216696A1 PCT/IB2017/053447 IB2017053447W WO2017216696A1 WO 2017216696 A1 WO2017216696 A1 WO 2017216696A1 IB 2017053447 W IB2017053447 W IB 2017053447W WO 2017216696 A1 WO2017216696 A1 WO 2017216696A1
Authority
WO
WIPO (PCT)
Prior art keywords
tubes
blood
tube
results
coefficient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2017/053447
Other languages
French (fr)
Inventor
Raouf MILAN NOURANI
Sasan SALMANIPOUR AVAL
Amir AZADKASB SALEH
Lida IMANI
Mahla SENFY
Seyyed Hadi MOUSAVI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2017216696A1 publication Critical patent/WO2017216696A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/15003Source of blood for venous or arterial blood

Definitions

  • the innovation refers to Medicine, biomedical engineering, Hygiene; Detecting, measuring or recording for diagnostic purposes; Investigating or analyzing materials by specific methods not covered by the preceding groups.
  • Tube method Blood typing test was formerly done on specific slides that is now considered obsolete and illegal. Afterwards, the tube method was substituted that is a safer and more scientific method. In tube method “three” tubes are used to determine the blood type that is, a scientific and international method. Moreover, instead of vibrating the slides on the shaker, after adding reagent antibodies, the tubes are placed in centrifuges with specific revolutions and time and then, proceed to perusal and interpret the results using eyesight and related cadre.
  • the second and primary problem that occurs in laboratories and institutes of blood transfusion is that for each person the blood typing is performed, e.g. likely the blood typing of 5, 10, 30 or even more persons are simultaneously done.
  • each of the three tubes are designed in one tube and for each of distinct spaces a hole is embedded to spill the blood and reagents of blood typing.
  • reagent A is always poured into the first cell and human mind gets used to it and a series of human errors get eliminated.
  • Using a tube for each person decreases the errors, besides.
  • the place of pouring blood, reagents, and also tubes are numbered so that after centrifuging the tubes each tube is placed on its former position which has the name and number of that particular person.
  • the box is cuboid which has 8 holes for placing each person’s sample before and after centrifuging and there are 8 holes to place each person’s test tube.
  • the box is designed to be additionally responsive for some of the serology slide tests and be usable for slide method if needed to immediately re-verify blood typing results which is a very important property.
  • the confidence coefficient will increase significantly since the major proportion of errors are due to this matter. For instance, the responding occurs after authentic reading of reply during writing the results in the sheet or reception to the system. Thus, re-check of result readings is possible without fully redoing the test and spending more expenses and work force.
  • the patient’s blood sample is placed in first cell. Then the special tube, that is numbered, is placed on the right hand and besides the person’s blood sample. Moreover, the required amount of blood is taken and poured into one the three spaces using the sampler.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Ecology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Blood typing by Facilitated tube method, the previous performance that was done disorderly and unstably by 3 tubes will now be performed by reducing the tubes to one and augmenting one special box which decreases human error and therefore improves of quality in any aspect. In what was done previously, due to the number of tubes in the entire test for several simultaneous persons and also the number of typing blood tubes for one of the three-to-four persons, alongside other difficulties that was the probability of mistaken patients' tubes, the amount of wasted time and energy was great and increasing. The purposes of invention: 1. Reducing human error, 2. Reducing waste of time, 3. Reducing expenses, 4. Increasing the factor of safety, 5. Removing the obsolete method and 6. Increasing the safety of patient over injecting blood product.

Description

Determining blood type by tube facilitated
The innovation refers to Medicine, biomedical engineering, Hygiene; Detecting, measuring or recording for diagnostic purposes; Investigating or analyzing materials by specific methods not covered by the preceding groups.
Blood typing test was formerly done on specific slides that is now considered obsolete and illegal. Afterwards, the tube method was substituted that is a safer and more scientific method. In tube method “three” tubes are used to determine the blood type that is, a scientific and international method. Moreover, instead of vibrating the slides on the shaker, after adding reagent antibodies, the tubes are placed in centrifuges with specific revolutions and time and then, proceed to perusal and interpret the results using eyesight and related cadre.
???
In former methods, due to the number of tubes that were 3 tubes for each person, difficulties were seen during reading test results at final stage of tubes centrifuge. For instance, while removing the tubes from centrifuge, the reordering of tubes was difficult and led to disorder in scanning tubes, interpreting results and reducing accuracy. For instance, once the tube was related to blood type A, the other related to B and Rh, mean that overall 9 variable states were imagined that led to increase of visual illusion.
The second and primary problem that occurs in laboratories and institutes of blood transfusion is that for each person the blood typing is performed, e.g. likely the blood typing of 5, 10, 30 or even more persons are simultaneously done.
Currently, e.g. for almost 30 persons about 90 tubes must consistently and regularly be contained with reagents, become centrifuged and ordered to be scanned.
Increasing the number of tubes and the persons that are to be tested makes the process of blood typing more difficult and error-prone and this is still an ongoing problem.
Presently, other manual methods that centrifuges and tube are not used within, e.g. slide methods all are obsolete and dated that will not be discussed however are now being used as a primary blood typing method illegally and obligatory since they’re easier to perform and have lower human error.
For solving the problem of tube quantity and inconsistency of tube emplacement during reading results in blood typing tube method, each of the three tubes are designed in one tube and for each of distinct spaces a hole is embedded to spill the blood and reagents of blood typing.
Now we have 3 distinct and stable spaces for pouring reagents each of which are labeled e.g. reagent A is always poured into the first cell and human mind gets used to it and a series of human errors get eliminated. Using a tube for each person decreases the errors, besides.
On the box, the place of pouring blood, reagents, and also tubes are numbered so that after centrifuging the tubes each tube is placed on its former position which has the name and number of that particular person.
The box is cuboid which has 8 holes for placing each person’s sample before and after centrifuging and there are 8 holes to place each person’s test tube.
There is a shining system embedded below the box to increase the contrast and resolution during reading.
The box is designed to be additionally responsive for some of the serology slide tests and be usable for slide method if needed to immediately re-verify blood typing results which is a very important property.
On top of the box, there are 3 holes embedded with the height of 2 centimeters that reagents of A, B, Rh are placed into. To provide the needed coldness, one container with the capability of being contained of ice is placed.
Using these methods, decreasing tubes leads to reducing overall coefficient of error.
Applicability of both methods, cell type and back type.
Because of the one-piece tube for each person, the pace and accuracy rises simultaneously and lesser space is needed, besides. Any decrease of mistaken blood typing will increase the coefficient of patient’s safety whom are nominated for blood reception and transplantation since the coincidence of patient’s and donor blood type will 99% fulfillment of the recipient
Because of the possibility of verifying and controlling the authenticity of results via a second person, the confidence coefficient will increase significantly since the major proportion of errors are due to this matter. For instance, the responding occurs after authentic reading of reply during writing the results in the sheet or reception to the system. Thus, re-check of result readings is possible without fully redoing the test and spending more expenses and work force.
Since no redoing of the test is required when suspicious of results of reading and interpreting, the need for redoing the test is omitted and eventually further expenses reduce dramatically.
Amplifying the patient safety to blood products
Fig.1
tube facilitated
1. First tube
2. Second tube
3. Third tube
stand
The patient’s blood sample is placed in first cell. Then the special tube, that is numbered, is placed on the right hand and besides the person’s blood sample. Moreover, the required amount of blood is taken and poured into one the three spaces using the sampler.
This process will be repeated for 7 other blood samples which are related to 7 further persons. Now the tubes will be carried over to centrifuge and after complementing the process and bringing the tubes out, they are placed to their former positions, say each person’s tube will lie alongside their blood sample to determine their blood type.
According to what was described above and demanding need of all domestic laboratories, industrial production is wholly economical and feasible.

Claims (8)

  1. Three required tubes for this experiment are placed and designed in one tube to avoid the confusion due to the number of tubes and with conditioning due to consistency and repetition of work stages, coefficient of error decreases. In addition to accuracy and authenticity of results, the pace is also improved.
  2. Using this method, decreasing the tubes will lead to reduction of coefficient of error.
  3. Applicability for both methods, cell type and back type.
  4. Because of the one-piece tube for each person, the pace and accuracy rises simultaneously and lesser space is needed, besides. Any decrease of mistaken blood typing will increase the coefficient of patient’s safety whom are nominated for blood reception and transplantation since the coincidence of patient’s and donor blood type will 99% fulfill the recipient
  5. Because of the possibility of verifying and controlling the authenticity of results via a second person, the confidence coefficient will increase significantly since the major proportion of errors are due to this matter. For instance, the responding occurs after authentic reading of reply during writing the results in the sheet or reception to the system. Thus, recheck of result readings is possible without fully redoing the test and spending more expenses and work force.
  6. Since no redoing of the test is required when suspicious of results of reading and interpreting, the need for redoing the test is omitted and eventually further expenses reduce dramatically.
  7. Amplifying the patient safety to blood products
  8. Tube with separation to 3 distinct parts
PCT/IB2017/053447 2016-06-15 2017-06-10 Determining blood type by tube facilitated Ceased WO2017216696A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IR13953003475 2016-06-15
IR139550140003003475 2016-06-15

Publications (1)

Publication Number Publication Date
WO2017216696A1 true WO2017216696A1 (en) 2017-12-21

Family

ID=83268085

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2017/053447 Ceased WO2017216696A1 (en) 2016-06-15 2017-06-10 Determining blood type by tube facilitated

Country Status (1)

Country Link
WO (1) WO2017216696A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203930B1 (en) * 1984-11-13 1990-07-11 Cedars-Sinai Medical Center Portable blood typing apparatus and method
WO1995031731A1 (en) * 1994-05-17 1995-11-23 Gamma Biologicals, Inc. Method and apparatus useful for detecting bloodgroup antigens and antibodies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203930B1 (en) * 1984-11-13 1990-07-11 Cedars-Sinai Medical Center Portable blood typing apparatus and method
WO1995031731A1 (en) * 1994-05-17 1995-11-23 Gamma Biologicals, Inc. Method and apparatus useful for detecting bloodgroup antigens and antibodies

Similar Documents

Publication Publication Date Title
Torlakovic et al. Getting controls under control: the time is now for immunohistochemistry
US9101926B2 (en) Method for separating a sample into density specific fractions
der Strate et al. Best practices in performing flow cytometry in a regulated environment: feedback from experience within the European Bioanalysis Forum
US20130045852A1 (en) Centrifuge separation method and apparatus using a medium density fluid
US10895570B2 (en) Method for determining the result of an agglutination reaction and microplate for determining products of agglutination reactions
IL274377B2 (en) Cartridge and system for analyzing body liquid
CN101493456B (en) Diluent wells produced in card format for immunodiagnostic testing
CN108226536A (en) The micro-fluidic immune detection chip and method of a kind of cardiac muscle troponin I
WO2017216696A1 (en) Determining blood type by tube facilitated
Roberts et al. Solid‐phase assays for the detection of alloantibody against human leukocyte antigens: Panacea or Pandora?
US20130122606A1 (en) Method and device for chemical and/or biological analysis
Sarkar et al. Assessment of platelet function by automated light transmission aggregometry
CN107462724A (en) The detection method of circulating tumor cell in blood
JP5220466B2 (en) HLA antibody analysis apparatus, method and program thereof
Judd et al. Reactivity of FDA-approved anti-D reagents with partial D red blood cells
AU2016223431B2 (en) Antibody detection method and system
Roback et al. Performance and reliability of a benchtop automated instrument for transfusion testing: a comparative multicenter clinical study in the US population
Mihalko et al. Microfluidics in assessing platelet function
JPH09507577A (en) Reaction column and method for multi-target simultaneous measurement
WO2020146826A1 (en) Device & method for saliva-based analyte testing
Weinstein et al. Blood typing and cross‐matching
JP6331524B2 (en) Standard cell solution
CN105973825B (en) A kind of whole blood biochemistry detection method and device
Setyanda et al. Screening and identification of erythrocyte antibodies: a narrative literature review
Roberts Antibody titration

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17812845

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17812845

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC. EPO FORM 1205A DATED 09.07.19

122 Ep: pct application non-entry in european phase

Ref document number: 17812845

Country of ref document: EP

Kind code of ref document: A1